The porphyrias are a group of uncommon disorders that affect the skin, the nervous system, or both. They arise when one of the enzymes in the chain of reactions that makes haem, a vital part of haemoglobin, is missing or faulty. Substances called porphyrins and their precursors then build up, sometimes to toxic levels.
Build-up in the skin causes sensitivity to sunlight, while build-up in the liver causes acute attacks. There are seven types: four acute porphyrias and three that mainly affect the skin.
The most common is porphyria cutanea tarda (PCT), which usually starts in middle age with blisters and fragile, scarred skin on sun-exposed areas, often triggered by heavy drinking or conditions such as hepatitis C. Acute intermittent porphyria (AIP) is inherited and, after puberty, causes attacks of severe abdominal pain, weakness and other nerve symptoms. Erythropoietic protoporphyria (EPP) often begins in childhood with painful sensitivity to the sun.
For someone with symptoms, the main tests measure porphyrins and their precursors in blood, urine and faeces. A urine porphobilinogen (PBG) test is the most important test for diagnosing an acute porphyria affecting the nerves. Porphyrin levels in urine, faeces, red blood cells and plasma help tell apart types with similar symptoms.
For relatives, or for people who may carry the condition without symptoms, enzyme activity in red blood cells and DNA testing for mutations are more useful. Pinning down the exact type often needs specialist biochemical or genetic testing.
In the acute porphyrias (AIP, variegate porphyria and hereditary coproporphyria), the key to preventing attacks is avoiding medicines known to trigger them. Strict dieting should be avoided, women are usually advised not to use the contraceptive pill, and attacks linked to the menstrual cycle may be prevented with hormonal treatment. For people with frequent attacks, givosiran, an RNA-based drug, reduces production of the toxic substances.
An acute attack is treated by removing triggers, giving a haem preparation such as haem arginate or haematin into a vein and providing enough nutrition, especially glucose. Severe attacks may need intensive care.
People with PCT should avoid alcohol and protect their skin from the sun; regular removal of blood (venesection) lowers iron levels, and chloroquine is an alternative. In EPP, thick covering clothing and beta-carotene help reduce sun sensitivity.
Someone diagnosed with porphyria many years ago may never have had another episode. The disease may simply have stayed quiet, or the original diagnosis may have been wrong, since older tests were less accurate.
Lists of safe and unsafe medicines often differ between sources. Information is incomplete because porphyria is rare and many drugs are new, so it can take years of use in people with the condition before a drug can be called safe.